Iguana Healthcare Management as of June 30, 2017
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 61 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 7.2 | $13M | 98k | 129.87 | |
| Alexion Pharmaceuticals | 4.1 | $7.3M | 60k | 121.67 | |
| Clovis Oncology | 4.0 | $7.0M | 75k | 93.63 | |
| Shire | 3.7 | $6.6M | 40k | 165.28 | |
| Merck & Co Inc New option | 3.6 | $6.4M | 100k | 64.09 | |
| Allergan | 3.4 | $6.1M | 25k | 243.08 | |
| Medicines Company | 3.2 | $5.7M | 150k | 38.01 | |
| Merck & Co (MRK) | 2.9 | $5.1M | 80k | 64.09 | |
| Aerie Pharmaceuticals | 2.8 | $5.0M | 95k | 52.55 | |
| Aetna | 2.8 | $4.9M | 33k | 151.82 | |
| K2m Group Holdings | 2.8 | $4.9M | 200k | 24.36 | |
| Global Blood Therapeutics In | 2.7 | $4.8M | 175k | 27.35 | |
| Ultragenyx Pharmaceutical (RARE) | 2.6 | $4.7M | 75k | 62.11 | |
| Esperion Therapeutics (ESPR) | 2.6 | $4.6M | 100k | 46.28 | |
| Spectranetics Corporation | 2.4 | $4.2M | 110k | 38.40 | |
| Eli Lilly & Co. (LLY) | 2.3 | $4.1M | 50k | 82.30 | |
| Dermira | 2.3 | $4.1M | 140k | 29.14 | |
| Clovis Oncology | 2.1 | $3.7M | 40k | 93.62 | |
| Sanofi-Aventis SA (SNY) | 2.0 | $3.6M | 75k | 47.91 | |
| ASTRAZENECA Plc-spons | 1.9 | $3.4M | 100k | 34.10 | |
| Zimmer Holdings (ZBH) | 1.8 | $3.2M | 25k | 128.40 | |
| ALEXION PHARMACEUTICALS INC CMN Stock cmn | 1.7 | $3.0M | 25k | 121.68 | |
| Juno Therapeutics | 1.7 | $3.0M | 100k | 29.89 | |
| CIGNA Corporation | 1.7 | $2.9M | 18k | 167.37 | |
| Abbvie (ABBV) | 1.6 | $2.9M | 40k | 72.50 | |
| Immunomedics | 1.6 | $2.9M | 325k | 8.83 | |
| Merus N V (MRUS) | 1.6 | $2.8M | 175k | 15.85 | |
| Karyopharm Therapeutics (KPTI) | 1.5 | $2.7M | 300k | 9.05 | |
| NuVasive | 1.5 | $2.7M | 35k | 76.91 | |
| Glaukos (GKOS) | 1.4 | $2.5M | 60k | 41.47 | |
| Avexis | 1.4 | $2.5M | 30k | 82.17 | |
| Chemocentryx | 1.3 | $2.3M | 250k | 9.36 | |
| Biomarin Pharmaceutical | 1.3 | $2.3M | 25k | 90.84 | |
| Tesaro | 1.2 | $2.1M | 15k | 139.87 | |
| Biogen Idec (BIIB) | 1.1 | $2.0M | 7.5k | 271.33 | |
| Intersect Ent | 1.1 | $2.0M | 70k | 27.96 | |
| Abbott Laboratories (ABT) | 1.1 | $1.9M | 40k | 48.60 | |
| Sangamo Biosciences (SGMO) | 1.1 | $1.9M | 215k | 8.80 | |
| Medtronic (MDT) | 1.0 | $1.8M | 20k | 88.75 | |
| Anaptysbio Inc Common (ANAB) | 0.9 | $1.7M | 70k | 23.93 | |
| Boston Scientific Corporation (BSX) | 0.9 | $1.5M | 55k | 27.73 | |
| Gw Pharmaceuticals Plc ads | 0.8 | $1.5M | 15k | 100.27 | |
| Immunomedics Inc Cmn Stk cmn | 0.8 | $1.3M | 150k | 8.83 | |
| Oncomed Pharmaceuticals | 0.8 | $1.3M | 400k | 3.33 | |
| Achaogen | 0.7 | $1.3M | 60k | 21.73 | |
| Zogenix | 0.7 | $1.2M | 85k | 14.51 | |
| Epizyme | 0.6 | $1.1M | 75k | 15.11 | |
| Diplomat Pharmacy | 0.6 | $1.1M | 75k | 14.80 | |
| Wave Life Sciences (WVE) | 0.6 | $1.0M | 55k | 18.60 | |
| Cytomx Therapeutics (CTMX) | 0.5 | $930k | 60k | 15.50 | |
| Edwards Lifesciences (EW) | 0.5 | $887k | 7.5k | 118.27 | |
| Xencor (XNCR) | 0.5 | $844k | 40k | 21.10 | |
| Corium Intl | 0.4 | $746k | 100k | 7.46 | |
| Sanofi Aventis | 0.4 | $719k | 15k | 47.93 | |
| Cymabay Therapeutics | 0.3 | $605k | 105k | 5.76 | |
| Adma Biologics (ADMA) | 0.3 | $555k | 150k | 3.70 | |
| Ignyta | 0.3 | $518k | 50k | 10.36 | |
| Neovasc | 0.3 | $483k | 350k | 1.38 | |
| Rite Aid Corporation | 0.2 | $443k | 150k | 2.95 | |
| Scynexis | 0.2 | $403k | 225k | 1.79 | |
| Obseva Sa | 0.1 | $257k | 30k | 8.57 |
